Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Correction to: Evaluation of hydrochar efficiency for simultaneous removal of diclofenac and ibuprofen from aqueous system using surface response methodology.

Qureshi T, Memon N, Memon SQ, Yavuz H, Lachgar A, Denizli A.

Environ Sci Pollut Res Int. 2019 Apr;26(10):9805. doi: 10.1007/s11356-019-04746-6.

PMID:
30868453
2.

Evaluation of hydrochar efficiency for simultaneous removal of diclofenac and ibuprofen from aqueous system using surface response methodology.

Qureshi T, Memon N, Memon SQ, Yavuz H, Lachgar A, Denizli A.

Environ Sci Pollut Res Int. 2019 Apr;26(10):9796-9804. doi: 10.1007/s11356-019-04359-z. Epub 2019 Feb 7. Erratum in: Environ Sci Pollut Res Int. 2019 Mar 13;:.

PMID:
30729442
3.

Interface Engineering of Colloidal CdSe Quantum Dot Thin Films as Acid-Stable Photocathodes for Solar-Driven Hydrogen Evolution.

Li H, Wen P, Hoxie A, Dun C, Adhikari S, Li Q, Lu C, Itanze DS, Jiang L, Carroll D, Lachgar A, Qiu Y, Geyer SM.

ACS Appl Mater Interfaces. 2018 May 23;10(20):17129-17139. doi: 10.1021/acsami.7b19229. Epub 2018 May 10.

PMID:
29712425
4.

[Pain flare following palliative external beam radiotherapy: Prospective study of 41 cases].

Lachgar A, Sahli N, Benjaafar N.

Cancer Radiother. 2017 Aug;21(5):373-376. doi: 10.1016/j.canrad.2017.01.011. Epub 2017 May 19. French.

PMID:
28532618
5.

Hypofractionated Regional Nodal Irradiation for Women With Node-Positive Breast Cancer.

Bellefqih S, Elmajjaoui S, Aarab J, Khalil J, Afif M, Lachgar A, El Kacemi H, Kebdani T, Benjaafar N.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):563-570. doi: 10.1016/j.ijrobp.2016.11.010. Epub 2016 Nov 15.

PMID:
28126305
6.

Lung cancer: Incidence and survival in Rabat, Morocco.

Lachgar A, Tazi MA, Afif M, Er-Raki A, Kebdani T, Benjaafar N.

Rev Epidemiol Sante Publique. 2016 Dec;64(6):391-395. doi: 10.1016/j.respe.2016.02.012. Epub 2016 Oct 25.

PMID:
27793413
7.

A Visible-Light-Active Heterojunction with Enhanced Photocatalytic Hydrogen Generation.

Adhikari SP, Hood ZD, More KL, Chen VW, Lachgar A.

ChemSusChem. 2016 Jul 21;9(14):1869-79. doi: 10.1002/cssc.201600424. Epub 2016 Jun 10.

PMID:
27282318
8.

Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response.

Thalmensi J, Pliquet E, Liard C, Escande M, Bestetti T, Julithe M, Kostrzak A, Pailhes-Jimenez AS, Bourges E, Loustau M, Caumartin J, Lachgar A, Huet T, Wain-Hobson S, Langlade-Demoyen P.

Oncoimmunology. 2015 Nov 5;5(3):e1083670. eCollection 2016 Mar.

9.

[Radiotherapy in the management of painful bone metastases at The National Institute of Oncology in Morocco: data from one year follow-up of 86 patients].

Lachgar A, Toulba A, Kebdani T, Elgueddari BK, Benjaafar N.

Tunis Med. 2015 Aug-Sep;93(8-9):574-7. French.

10.

[Lung cancer: treatment pathway in the radiotherapy department at the National Oncology Institute of Rabat].

Lachgar A, Sahli N, Toulba A, Kebdani T, Benjaafar N.

Pan Afr Med J. 2015 Aug 6;21:253. doi: 10.11604/pamj.2015.21.253.6627. eCollection 2015. French. No abstract available.

11.

Octahedral metal clusters as building blocks of trimetallic superexpanded Prussian blue analogues.

Zhang JJ, Lachgar A.

Inorg Chem. 2015 Feb 2;54(3):1082-90. doi: 10.1021/ic502401n. Epub 2015 Jan 15.

PMID:
25590572
12.

Silicon sheets by redox assisted chemical exfoliation.

Tchalala MR, Ali MA, Enriquez H, Kara A, Lachgar A, Yagoubi S, Foy E, Vega E, Bendounan A, Silly MG, Sirotti F, Nitshe S, Chaudanson D, Jamgotchian H, Aufray B, Mayne AJ, Dujardin G, Oughaddou H.

J Phys Condens Matter. 2013 Nov 6;25(44):442001.

PMID:
24131870
13.

A comparative study of solid carbon acid catalysts for the esterification of free fatty acids for biodiesel production. Evidence for the leaching of colloidal carbon.

Deshmane CA, Wright MW, Lachgar A, Rohlfing M, Liu Z, Le J, Hanson BE.

Bioresour Technol. 2013 Nov;147:597-604. doi: 10.1016/j.biortech.2013.08.073. Epub 2013 Aug 20.

PMID:
24021721
14.

[Urinary tract infections in elderly].

Ben Dhaou Hmaidi B, Boussema F, Aydi Z, Baili L, Ketari S, Ben Rhouma S, Lachgar A, Cherif O, Rokbani L.

Tunis Med. 2011 Dec;89(12):920-3. French.

15.

Directed assembly of cluster-based supramolecules into one-dimensional coordination polymers.

Zhang JJ, Zhou HJ, Lachgar A.

Angew Chem Int Ed Engl. 2007;46(26):4995-8. No abstract available.

PMID:
17415733
16.

Superexpanded Prussian-blue analogue with [Fe(CN)6]4-, [Nb6Cl12(CN)6]4-, and [Mn(salen)]+ as building units.

Zhang J, Lachgar A.

J Am Chem Soc. 2007 Jan 17;129(2):250-1. No abstract available.

PMID:
17212385
17.
18.

Octahedral metal clusters as building units in a neutral layered honeycomb network, [Zn(en)]2[Nb6Cl12(CN)6].

Yan B, Day CS, Lachgar A.

Chem Commun (Camb). 2004 Nov 7;(21):2390-1. Epub 2004 Sep 14.

PMID:
15514780
19.

Octahedral niobium chloride clusters as building blocks of templated prussian blue framework analogues.

Yan B, Zhou H, Lachgar A.

Inorg Chem. 2003 Dec 29;42(26):8818-22.

PMID:
14686862
20.
21.

Potassium yttrium hexaniobium octadecachloride, KYNb6Cl18.

Duraisamy T, Lachgar A.

Acta Crystallogr C. 2003 Apr;59(Pt 4):I27-8. Epub 2003 Mar 21.

PMID:
12682382
22.

Structural studies of indium and thallium insertion into the framework of the cluster compound Ti2Nb6Cl14O4.

Anokhina E, Essig M, Day C, Lachgar A.

Inorg Chem. 2000 May 15;39(10):2185-8.

PMID:
12526533
23.

K(2)SrNb(6)Cl(18), dipotassium strontium hexaniobium octadecachloride.

Duraisamy T, Lachgar A.

Acta Crystallogr C. 2002 Jun;58(Pt 6):i85-6. Epub 2002 May 21.

PMID:
12050409
24.

Synthesis, Crystal Structure, NMR Studies, and Thermal Stability of Mixed Iron-Indium Phosphates with Quasi-One-Dimensional Frameworks.

Tang X, Jones A, Lachgar A, Gross BJ, Yarger JL.

Inorg Chem. 1999 Dec 27;38(26):6032-6038.

PMID:
11671310
25.
26.

Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes.

Le Buanec H, Vetu C, Lachgar A, Benoit MA, Gillard J, Paturance S, Aucouturier J, Gane V, Zagury D, Bizzini B.

Biomed Pharmacother. 2001 Jul;55(6):316-20.

PMID:
11478583
28.

HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes.

Le Buanec H, D'Anna R, Lachgar A, Zagury JF, Bernard J, Ittelé D, d'Alessio P, Hallez S, Giannouli C, Burny A, Bizzini B, Gallo RC, Zagury D.

Biomed Pharmacother. 1999 Oct;53(9):424-31.

PMID:
10554678
29.

Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic protein.

Le Buanec H, Lachgar A, D'Anna R, Zagury JF, Bizzini B, Bernard J, Ittelé D, Hallez S, Giannouli C, Burny A, Zagury D.

Biomed Pharmacother. 1999 Aug;53(7):323-8.

PMID:
10472433
30.

Lectin production by human T-lymphocytes.

Lachgar A, Le Buanec H, Burny A, Bizzini B, Zagury D.

Biomed Pharmacother. 1999 Jun;53(5-6):288-9.

PMID:
10424253
31.

IFN alpha kinoid vaccine in conjunction with tritherapy, a weapon to combat immunopathogenesis in AIDS.

Bizzini B, Volpato I, Lachgar A, Cohen P, Gringeri A.

Biomed Pharmacother. 1999 Mar;53(2):87-9. Review.

PMID:
10337462
32.

Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients.

Gringeri A, Santagostino E, Muça-Perja M, Mannucci PM, Zagury JF, Bizzini B, Lachgar A, Carcagno M, Rappaport J, Criscuolo M, Blattner W, Burny A, Gallo RC, Zagury D.

J Hum Virol. 1998 May-Jun;1(4):293-8.

PMID:
10195254
33.

Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: a rationale for the use of Tat toxoid as an HIV-1 vaccine.

Zagury JF, Sill A, Blattner W, Lachgar A, Le Buanec H, Richardson M, Rappaport J, Hendel H, Bizzini B, Gringeri A, Carcagno M, Criscuolo M, Burny A, Gallo RC, Zagury D.

J Hum Virol. 1998 May-Jun;1(4):282-92.

PMID:
10195253
34.

Tat toxoid as a component of a preventive vaccine in seronegative subjects.

Gringeri A, Santagostino E, Muça-Perja M, Le Buanec H, Bizzini B, Lachgar A, Zagury JF, Rappaport J, Burny A, Gallo RC, Zagury D.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Apr 1;20(4):371-5.

PMID:
10096581
35.

Binding of HIV-1 to RBCs involves the Duffy antigen receptors for chemokines (DARC).

Lachgar A, Jaureguiberry G, Le Buenac H, Bizzini B, Zagury JF, Rappaport J, Zagury D.

Biomed Pharmacother. 1998;52(10):436-9.

PMID:
9921412
36.

A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat toxoid.

Le Buanec H, Lachgar A, Bizzini B, Zagury JF, Rappaport J, Santagostino E, Muça-Perja M, Gringeri A.

Biomed Pharmacother. 1998;52(10):431-5.

PMID:
9921411
37.

Amplification of the inflammatory cellular redox state by human immunodeficiency virus type 1-immunosuppressive tat and gp160 proteins.

Lachgar A, Sojic N, Arbault S, Bruce D, Sarasin A, Amatore C, Bizzini B, Zagury D, Vuillaume M.

J Virol. 1999 Feb;73(2):1447-52.

38.

Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progression.

Hendel H, Hénon N, Lebuanec H, Lachgar A, Poncelet H, Caillat-Zucman S, Winkler CA, Smith MW, Kenefic L, O'Brien S, Lu W, Andrieu JM, Zagury D, Schächter F, Rappaport J, Zagury JF.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):381-6.

PMID:
9833747
39.

C-C chemokines, pivotal in protection against HIV type 1 infection.

Zagury D, Lachgar A, Chams V, Fall LS, Bernard J, Zagury JF, Bizzini B, Gringeri A, Santagostino E, Rappaport J, Feldman M, O'Brien SJ, Burny A, Gallo RC.

Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3857-61.

40.

Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.

Zagury D, Lachgar A, Chams V, Fall LS, Bernard J, Zagury JF, Bizzini B, Gringeri A, Santagostino E, Rappaport J, Feldman M, Burny A, Gallo RC.

Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3851-6.

41.

Ti2 Nb6 Cl14 O4 : A Unique 2D-1D Network Combination in Niobium Cluster Chemistry.

Anokhina EV, Essig MW, Lachgar A.

Angew Chem Int Ed Engl. 1998 Mar 2;37(4):522-525. doi: 10.1002/(SICI)1521-3773(19980302)37:4<522::AID-ANIE522>3.0.CO;2-Y.

PMID:
29711150
42.

Potentialization of IL-2 effects on immune cells by oyster extract (JCOE) in normal and HIV-infected individuals.

Achour A, Lachgar A, Astgen A, Chams V, Bizzini B, Tapiero H, Zagury D.

Biomed Pharmacother. 1997;51(10):427-9.

PMID:
9863500
43.

Absence of clinical, virological, and immunological signs of progression in HIV-1-infected patients receiving active anti-interferon-alpha immunization: a 30-month follow-up report.

Gringeri A, Santagostino E, Cusini M, Muça-Perja M, Marinoni A, Mannucci PM, Burny A, Criscuolo M, Lu W, Andrieru JM, Mbika JP, Lachgar A, Fall LS, Chams V, Feldman M, Hermans P, Zagury JF, Bizzini B, Musicco M, Zagury D.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Sep;13(1):55-67.

PMID:
8797687
44.

Repair of the in vitro HIV-1-induced immunosuppression and blockade of the generation of functional suppressive CD8 cells by anti-alpha interferon and anti-Tat antibodies.

Lachgar A, Bernard J, Bizzini B, Astgen A, Le Coq H, Fouchard M, Chams V, Feldman M, Burny A, Zagury JF.

Biomed Pharmacother. 1996;50(1):13-8.

PMID:
8672726
45.

Automat and BLAST: comparison of two protein sequence similarity search programs.

Cantalloube H, Labesse G, Chomilier J, Nahum C, Cho YY, Chams V, Achour A, Lachgar A, Mbika JP, Issing W, et al.

Comput Appl Biosci. 1995 Jun;11(3):261-72.

PMID:
7583694
46.

Contribution of alpha interferon (alpha IFN) to HIV-induced immunosuppression.

Lachgar A, Bizzini B.

Cell Mol Biol (Noisy-le-grand). 1995 May;41(3):431-7.

PMID:
7580838
47.

Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis?

Zagury JF, Chams V, Lachgar A, Achour A, Bizzini B, Burny A, Zagury D, Feldman M.

Cell Death Differ. 1995 Jan;2(1):23-32.

PMID:
17180012
48.

Syngeneic adoptive transfer of anti-human immunodeficiency virus (HIV-1)-primed lymphocytes from a vaccinated HIV-seronegative individual to his HIV-1-infected identical twin.

Bex F, Hermans P, Sprecher S, Achour A, Badjou R, Desgranges C, Cogniaux J, Franchioli P, Vanhulle C, Lachgar A, et al.

Blood. 1994 Nov 15;84(10):3317-26.

49.
50.

Pathogenic disorders involved in immunosuppression and T cell depletion characterizing AIDS.

Zagury JF, Lachgar A, Achour A, Chams-Harvey V, Cho YY, Le Coq H, Bizzini B, Feldman M, Burny A, Zagury D.

Biomed Pharmacother. 1994;48(1):11-6.

PMID:
7919098

Supplemental Content

Loading ...
Support Center